Journey Clinical Revenue and Competitors
Estimated Revenue & Valuation
- Journey Clinical's estimated annual revenue is currently $30M per year.
- Journey Clinical's estimated revenue per employee is $282,736
Employee Data
- Journey Clinical has 106 Employees.
- Journey Clinical grew their employee count by 34% last year.
Journey Clinical's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-founder & CEO | Reveal Email/Phone |
2 | Co-Founder & COO | Reveal Email/Phone |
3 | Chief Staff | Reveal Email/Phone |
4 | Head Engineering | Reveal Email/Phone |
5 | Head Development & Innovation | Reveal Email/Phone |
6 | Medical Director | Reveal Email/Phone |
7 | Sales Director | Reveal Email/Phone |
8 | California Medical Director | Reveal Email/Phone |
9 | Team Lead, Senior Customer Success Manager | Reveal Email/Phone |
10 | Experiential Training Program Manager, Client Success | Reveal Email/Phone |
Journey Clinical Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.5M | 30 | -6% | N/A | N/A |
#2 | $15.3M | 63 | 15% | N/A | N/A |
#3 | $27.3M | 101 | 7% | N/A | N/A |
#4 | $115.1M | 341 | 16% | N/A | N/A |
#5 | $9.3M | 43 | 0% | N/A | N/A |
#6 | $56.7M | 191 | 11% | N/A | N/A |
#7 | $65M | 219 | 0% | N/A | N/A |
#8 | $57.9M | 195 | 9% | N/A | N/A |
#9 | $8.6M | 40 | -11% | N/A | N/A |
#10 | $10.4M | 48 | 9% | N/A | N/A |
What Is Journey Clinical?
Expanding access to Psychedelic-Assisted Psychotherapy, starting with Ketamine-Assisted Psychotherapy (KAP). Currently supporting licensed mental health professionals in New York, California, New Jersey, Massachusetts + Colorado.
keywords:N/AN/A
Total Funding
106
Number of Employees
$30M
Revenue (est)
34%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $30.7M | 106 | 8% | N/A |
#2 | $28.6M | 106 | 14% | N/A |
#3 | $24.1M | 106 | 3% | N/A |
#4 | $15.9M | 106 | 9% | N/A |
#5 | $28.6M | 106 | 5% | N/A |